Congruence rates for pharmacogenomic noninterruptive alerts
Pharmacogenomics, ISSN: 1744-8042, Vol: 24, Issue: 9, Page: 493-500
2023
- 2Citations
- 5Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- CrossRef2
- Captures5
- Readers5
- Mentions1
- News Mentions1
- 1
Most Recent News
New Findings Reported from Sanford Health Describe Advances in Pharmacogenomics (Congruence Rates for Pharmacogenomic Noninterruptive Alerts)
2023 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech News Daily -- Investigators publish new report on Biotechnology - Pharmacogenomics. According
Article Description
Meaningful clinical decision support (CDS) recommendations are vital for implementation of pharmacogenomics (PGx) into routine clinical care. PGx CDS alerts include interruptive and noninterruptive alerts. The objective of this study was to evaluate provider ordering behavior after noninterruptive alerts are displayed. A retrospective manual chart review was conducted from the time of noninterruptive alert implementation to the time of data analysis to determine congruence with CDS recommendations. The congruence rate for noninterruptive alerts was 89.8% across all drug-gene interactions. The drug-gene interaction with the most alerts for analysis included metoclopramide (n = 138). The high rate of medication order congruence after noninterruptive alerts were deployed suggests this modality may be appropriate for PGx CDS as a method for best practice adherence.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85168222624&origin=inward; http://dx.doi.org/10.2217/pgs-2023-0016; http://www.ncbi.nlm.nih.gov/pubmed/37435734; https://www.tandfonline.com/doi/full/10.2217/pgs-2023-0016; https://dx.doi.org/10.2217/pgs-2023-0016; https://www.futuremedicine.com/doi/10.2217/pgs-2023-0016
Informa UK Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know